Published in

Newlands Press, Therapeutic Delivery, 10(2), p. 1313-1324, 2011

DOI: 10.4155/tde.11.100

Links

Tools

Export citation

Search in Google Scholar

Pulmonary delivery of inhalable nanoparticles: Dry powder inhalers

Journal article published in 2011 by Mhd Kamal Al-Hallak, M. H. D. Kamal Al Hallak, Muhammad Khan Sarfraz ORCID, Shirzad Azarmi, Wilson H. Roa, Warren H. Finlay, Raimar Löbenberg
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Pulmonary administration of inhalable nanoparticles (NPs) is an emerging area of interest. Dry powder inhalers may offer particular advantages for pulmonary administration of NPs. This article reviews research performed on the formulation of inhalable NPs as dry powder to achieve deep-lung deposition and enhance NP redispersibility. Moreover, the article summarizes up-to-date in vivo applications of inhalable NPs as dry powder inhalers.